Ashurst advised Volac International Limited on the deal. Stephenson Harwood LLP has advised the Denkavit Group on its acquisition. Volac International Limited, a world leader in...
Denkavit’s Acquisition of Volac International Ltd’ Milk Replacer Business
Novacyt’s £16.7m Takeover of Yourgene Health
Stephenson Harwood advised Novacyt on Yourgene Health takeover. Novacyt UK, a diagnostics company, has agreed to acquire UK-based genomic medicine firm Yourgene Health in a £16.7...
Oxford Biomedica’s Agreement With AstraZeneca UK Ltd
Stephenson Harwood LLP has advised Oxford Biomedica on the deal. Oxford Biomedica, the gene and cell therapy company, on its new three year Master Services &...
AM-Pharma’s €245 Million License Agreement With Kyowa Kirin
Stephenson Harwood LLP has advised AM-Pharma on the deal. AM-Pharma signed a €245 million exclusive license agreement deal with Kyowa Kirin, for the development and commercialisation...